π
|
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study.
12 auth.
K. Schnippel,
N. Ndjeka,
G. Maartens,
G. Meintjes,
I. Master,
N. Ismail,
...
J. Hughes,
Hannetjie Ferreira,
X. Padanilam,
R. Romero,
Julian te Riele,
F. Conradie
|
7 |
2018 |
7 π
|
π
|
Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study.
23 auth.
K. Dheda,
J. Limberis,
E. Pietersen,
J. Phelan,
A. Esmail,
M. Lesosky,
K. Fennelly,
Julian te Riele,
B. Mastrapa,
E. Streicher,
...
T. Dolby,
A. Abdallah,
F. Ben-Rached,
John A. Simpson,
Liezel Smith,
T. Gumbo,
P. V. van Helden,
F. Sirgel,
R. McNerney,
G. Theron,
A. Pain,
T. Clark,
R. Warren
|
6 |
2017 |
6 π
|
π
|
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen
18 auth.
N. Ndjeka,
K. Schnippel,
I. Master,
G. Meintjes,
G. Maartens,
R. Romero,
X. Padanilam,
M. Enwerem,
Sunitha Chotoo,
Nalini Singh,
...
J. Hughes,
E. Variava,
Hannetjie Ferreira,
Julian te Riele,
N. Ismail,
E. Mohr,
N. Bantubani,
F. Conradie
|
6 |
2018 |
6 π
|
π
|
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study.
24 auth.
N. Ismail,
S. Omar,
Harry Moultrie,
Z. Bhyat,
F. Conradie,
M. Enwerem,
Hannetjie Ferreira,
J. Hughes,
L. Joseph,
Y. Kock,
...
Vancy Letsaolo,
G. Maartens,
G. Meintjes,
D. Ngcamu,
N. Okozi,
X. Padanilam,
A. Reuter,
R. Romero,
S. Schaaf,
Julian te Riele,
E. Variava,
Minty van der Meulen,
F. Ismail,
N. Ndjeka
|
5 |
2021 |
5 π
|
π
|
Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis
15 auth.
G. Theron,
J. Limberis,
R. Venter,
Liezel Smith,
E. Pietersen,
A. Esmail,
G. Calligaro,
Julian te Riele,
Marianna de Kock,
P. V. van Helden,
...
T. Gumbo,
T. Clark,
K. Fennelly,
R. Warren,
K. Dheda
|
5 |
2020 |
5 π
|
π
|
An All-Oral 6-Month Regimen for Multidrug-Resistant TB (the NExT Study): A Multicenter, Randomized Controlled Trial.
24 auth.
A. Esmail,
S. Oelofse,
C. Dufauret Lombard,
R. Perumal,
Linda Mbuthini,
A. Goolam Mahomed,
E. Variava,
J. Black,
P. Oluboyo,
Nelile Gwentshu,
...
Eric Ngam,
Tertius Ackerman,
Linde Marais,
L. Mottay,
S. Meier,
A. Pooran,
M. Tomasicchio,
Julian te Riele,
B. Derendinger,
N. Ndjeka,
G. Maartens,
R. Warren,
N. Martinson,
K. Dheda
|
4 |
2022 |
4 π
|
π
|
Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study
21 auth.
J. Brust,
N. Gandhi,
S. Wasserman,
G. Maartens,
S. Omar,
N. Ismail,
A. Campbell,
L. Joseph,
Alexandria L. Hahn,
Salim Allana,
...
Alfonso C. HernΓ‘ndez-Romieu,
Chenshu Zhang,
K. Mlisana,
C. Viljoen,
Benjamin Zalta,
I. Ebrahim,
Meghan Franczek,
I. Master,
L. Ramangoaela,
Julian te Riele,
G. Meintjes
|
4 |
2021 |
4 π
|
π
|
High Frequency of Resistance, Lack of Clinical Benefit, and Poor Outcomes in Capreomycin Treated South African Patients with Extensively Drug-Resistant Tuberculosis
11 auth.
E. Pietersen,
J. Peter,
E. Streicher,
Frik A. Sirgel,
N. Rockwood,
B. Mastrapa,
...
Julian te Riele,
M. Davids,
P. V. van Helden,
R. Warren,
K. Dheda
|
4 |
2015 |
4 π
|
π
|
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
24 auth.
B. Derendinger,
A. Dippenaar,
M. de Vos,
Stella Huo,
Rencia Alberts,
Rebecca Tadokera,
J. Limberis,
Frik A. Sirgel,
T. Dolby,
Claudia Spies,
...
A. Reuter,
M. Folkerts,
C. Allender,
D. Lemmer,
Annelies Van Rie,
S. Gagneux,
L. Rigouts,
Julian te Riele,
K. Dheda,
D. Engelthaler,
Robin Warren,
John Metcalfe,
Helen Cox,
Grant Theron
|
4 |
2023 |
4 π
|